Literature DB >> 1821222

Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior.

E F Coccaro1, P D Harvey, E Kupsaw-Lawrence, J L Herbert, D P Bernstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821222

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  45 in total

1.  Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.

Authors:  S M Dursun; A Szemis; H Andrews; P Whitaker; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Update on pharmacotherapy of borderline personality disorder.

Authors:  Mary C Zanarini
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

3.  Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Authors:  Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Robert L Findling; Oscar G Bukstein; Nicole V Brown; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi L Kipp; Jayne Schneider; Cristan A Farmer; Jennifer L Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Eric M Butter; Kristin A Buchan-Page; Elizabeth A Hurt; Adrienne B Austin; Sabrina N Grondhuis; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-12       Impact factor: 8.829

4.  Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.

Authors:  Emil F Coccaro; Royce Lee; Elizabeth C Breen; Michael R Irwin
Journal:  Psychiatry Res       Date:  2015-07-29       Impact factor: 3.222

Review 5.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.

Authors:  Francis E Lotrich; Barry Sears; Robert K McNamara
Journal:  J Psychosom Res       Date:  2013-07-26       Impact factor: 3.006

Review 7.  Treating nonsuicidal self-injury: a systematic review of psychological and pharmacological interventions.

Authors:  Brianna J Turner; Sara B Austin; Alexander L Chapman
Journal:  Can J Psychiatry       Date:  2014-11       Impact factor: 4.356

8.  Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.

Authors:  Eric Hollander; William Chaplin; Latha Soorya; Stacey Wasserman; Sherry Novotny; Jade Rusoff; Nicole Feirsen; Lauren Pepa; Evdokia Anagnostou
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

Review 9.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder.

Authors:  David L Perez; David R Vago; Hong Pan; James Root; Oliver Tuescher; Benjamin H Fuchs; Lorene Leung; Jane Epstein; Nicole M Cain; John F Clarkin; Mark F Lenzenweger; Otto F Kernberg; Kenneth N Levy; David A Silbersweig; Emily Stern
Journal:  Psychiatry Clin Neurosci       Date:  2015-10-08       Impact factor: 5.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.